Agilent Technologies Inc (A) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Agilent Technologies inc   (NYSE: A)
 

Agilent Technologies Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Agilent Technologies Inc 's inventory turnover ratio sequentially decreased to 3.2 in the third quarter 2026, unsurprisingly, as the Agilent Technologies Inc markets continue to deteriorate, and A's faces growing challenges to bring down its inventories. Agilent Technologies Inc 's average inventory processing period in the Jul 31 2026 quarter, has increased to 114 days, from 111 days, in the Apr 30 2026 quarter.

Within Healthcare sector 120 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. 1050.

A Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Agilent Technologies Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

A Inventory Turnover Ratio (Jul 31 2026)
III. Quarter		 (Apr 30 2026)
II. Quarter		 (Jan 31 2026)
I. Quarter		 (Oct 31 2025)
IV. Quarter		 (Jul 31 2025)
III. Quarter
Y / Y Inventory Growth 10.16 % 9.89 % 5.45 % 5.45 % 3.68 %
Y / Y Cost of Sales Growth -1.65 % 5.36 % 8.95 % 10.96 % 17.57 %
Inventory Turnover Ratio (TTM) 3.2 3.29 3.33 3.3 3.26
A's Total Ranking # 1050 # 1050 # 798 # 1074 # 1013
Average inventory processing period 114 111 110 110 112
Seq. Inventory Growth 2.57 % 6.24 % 0 % 1.08 % 2.32 %
Seq. Cost of Sales Growth -1.07 % -0.82 % -2.18 % 2.47 % 5.99 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 121
Overall Market # 1050

Inventory Turnover Ratio Statistics
High Average Low
4.58 3.5 2.13
(Jul 31 2016)   (July 31, 2014)



A Company Profile >> Back to A Efficiency Comparisons >> Compare A Inventory Turnover Ratio to its Competitors

Financial Statements
Agilent Technologies Inc 's Inventories $ 1,117 Millions Visit A's Balance sheet
Agilent Technologies Inc 's Cost of Revenues TTM $ 3,404 Millions Visit A's Income Statement
What are A's Sales? Visit A's Sales by Segment

Other Inventory Turnover Ratios
Agilent Technologies Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
A's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for A's Competitors
Inventory Turnover Ratio for A's Suppliers
Inventory Turnover Ratio for A's Customers

You may also want to know
A's Sales Growth Rates A's Pe Price to earnings ratio A's Receivables Turnover Ratio A's Stock Quote
A's Net Income Growth Rates A's Ps Price to Sales ratio A's Sales per Employee A's Asset Turnover Ratio
A's Net Margin A's Pb Price to Book ratio A's Financial Strength Ratios A's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 31 2026 Inventories at quarter ending Jul 31 2026
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions

Date modified: 2026-09-26T07:19:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.